INSTITUTO DE INVESTIGACIÓN BIOMÉDICA DE SALAMANCA
Institute
Instituto de Investigación Sanitaria Fundación para la Investigación del Hospital Clínico de Valencia
Valencia, EspañaPublications in collaboration with researchers from Instituto de Investigación Sanitaria Fundación para la Investigación del Hospital Clínico de Valencia (7)
2022
-
Genetic variants in obesity-related genes and the risk of osteoporotic fracture. The Hortega Follow-up Study
Frontiers in bioscience (Landmark edition), Vol. 27, Núm. 1, pp. 32
2021
-
Real-world evidence of tisagenlecleucel for the treatment of relapsed or refractory large B-cell lymphoma
Cancer Medicine, Vol. 10, Núm. 10, pp. 3214-3223
2020
-
Resultados de una encuesta sobre el soporte nutricional perioperatorio en la cirugía pancreática y biliar en España
Nutricion hospitalaria, Vol. 37, Núm. 2, pp. 238-242
2019
-
Time dependent expression of the blood biomarkers EIF2D and TOX in patients with schizophrenia
Brain, Behavior, and Immunity, Vol. 80, pp. 909-915
2017
-
Defective cyclin B1 induction in trastuzumab-emtansine (T-DM1) acquired resistance in HER2-positive breast cancer
Clinical Cancer Research, Vol. 23, Núm. 22, pp. 7006-7019
-
Outcome of lower-risk patients with myelodysplastic syndromes without 5q deletion after failure of erythropoiesis-stimulating agents
Journal of Clinical Oncology, Vol. 35, Núm. 14, pp. 1591-1597
2002
-
Nonmyeloablative transplantation with or without alemtuzumab: Comparison between 2 prospective studies in patients with lymphoproliferative disorders
Blood, Vol. 100, Núm. 9, pp. 3121-3127